Overview
Status
Active
Registry date
2019-05-13
Share capital
5 000,00 PLN
Registered address
Skwer Kard. Stefana Wyszyńskiego 5/6u, 01-015 Warszawa, Poland
Electronic delivery address
AE:PL-12342-68645-RCFES-21
Financials
Revenue history
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 179.88MedianUSD 874.80kAverageUSD 20.30m
Net profit
This companyUSD -252.35MedianUSD 28.22kAverageUSD 816.54k
Operating costs
This companyUSD 405.90MedianUSD 805.63kAverageUSD 19.09m
Assets
This companyUSD 67.17MedianUSD 541.73kAverageUSD 10.95m
Industry
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Oct 1, 2025 | Call to creditors |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Karol Szczepan Korda – Liquidator
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Verco S.A. | 100 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Vorwarts Pharmasp. z o.o. | $210,138.62 | vorwartspharma.pl | ||
| Black & Whitesp. z o.o. | $154,866.36 | polonus.pl | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| THC PharmaS.A. | $39,093.70 | thc-pharma.pl | ||
| EDGE Pharmasp. z o.o. | $19,855.64 | edgepharma.eu | ||
| Arcade Internationalsp. z o.o. | $17,817.26 | arcade-int.pl | ||
| Filicosp. z o.o. | $11,710.75 | filico.eu | ||
| Get Ready Wheelchairssp. z o.o. | $9,842.54 | getreadywheelchairs.com | ||
| Jacek Waksmundzki Trust 2S.K.A. | $5,769.53 | trust.pl | ||
| Optimedussp. z o.o. | $1.00 | optimedus.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-10-07 | Name change (Ofta Pharma → Ofta Pharma Spółka Z Ograniczoną Odpowiedzialnością W Likwidacji) | |
| 2025-09-17 | Liquidation opened | |
| 2019-05-13 | Entered in the register |
FAQ
The main business activity of Ofta Pharma focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on May 13, 2019.
The headquarters is located at: Skwer Kard. Stefana Wyszyńskiego 5, 01-015 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from September 17, 2025 to December 31, 2025.
In 2025, the company's revenue reached $180.
No, in 2025 the company was not profitable, reporting a net loss of $252. For comparison, in 2024 the loss was $561, meaning the company reduced its loss by 55.2%.
The largest operating cost category falls under external services. This category amounted to $226 in 2025, representing 56% of all operating expenses.
Last updated: 2026-10-07